World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2800)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

151

HTML

1118

Figures (1-3)

290

Tables (1-4)

249

Sum=1808

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

148

Download

733

Sum=881

Apr 15, 2025 (publication date) through Mar 24, 2026

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Lu JL, Cheng Y, Xu ZL, Qian GX, Wei MT, Jia WD. Immune checkpoint inhibitors plus anti-angiogenesis in patients with resected high-risk hepatitis B virus-associated hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(4): 101371 [PMID: 40235869 DOI: 10.4251/wjgo.v17.i4.101371]
URL:	https://www.wjgnet.com/1948-5204/full/v17/i4/101371.htm

Number	Citing Articles
1	Arunkumar Krishnan, Diptasree Mukherjee. Postoperative immune checkpoint inhibitors plus anti-angiogenesis for hepatitis B virus-associated hepatocellular carcinoma: Analyzing the evidence and future prospects. World Journal of Gastrointestinal Oncology 2025; 17(9): 106801 doi: 10.4251/wjgo.v17.i9.106801 Abstract(57) \| Core Tip(59) \| Full Article(HTML)(139) \| Full Article with Cover (PDF)-722K(39) \| Audio-268K(23) \| Peer-Review Report-225K(27) \| Answering Reviewers-66K(30) \| Full Article (PDF)-396K(50) \| Full Article (XML)-64K(37) \| Times Cited (0) \| Total Visits (1190) \| Open
2	Ziyue Huang, Taifeng Zhu, Xiaokun Chen, Mingjian Piao, Yang Tan, Chengjie Li, Kai Liu, Shanshan Wang, Lei Zhang, Shunda Du, Chengpei Zhu, Kang Zhou, Xiaobo Yang, Daobing Zeng, Haitao Zhao. Postoperative adjuvant TACE combined with lenvatinib and immune checkpoint inhibitors for hepatocellular carcinoma with high recurrence risks: a multicenter retrospective study. BMC Cancer 2026; 26(1) doi: 10.1186/s12885-026-15586-2